Condition

Avascular Necrosis of Femur Head clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Avascular Necrosis of Femur Head clinical trials that are recruiting, at sites in 3 countries (most in China (1), France (1), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Avascular Necrosis of Femur Head clinical trials

StudyPhaseWhereStatusRegistered
Povidone-iodine versus chlorhexidine wound wash after total hip replacement — Monroeville, Pennsylvania and 1 other locations Recruiting Aug 5, 2025
Autologous bone marrow stem cell–seeded scaffold to repair early femoral head avascular necrosis — Xinxiang, Henan Recruiting Aug 3, 2025
Assessing the performance of a specific hip implant in patients needing hip replacement — Saint-Jean Recruiting Oct 15, 2024

All recruiting trials (3)

Related topics

Hip Osteoarthritis

Quick answers

How many Avascular Necrosis of Femur Head clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (1 trial), France (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.